Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05732532 · ClinicalTrials.gov registry record · Phase 4
Steroids in Occipital Nerve Block for Treatment of Headache
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT05732532: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT05732532 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05732532, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
Currently there is limited evidence of benefit for the addition of steroids to occipital nerve blocks for treatment of headache, and not all steroids have been explored. The purpose of this research is to learn more about whether the addition of a specific kind of steroid (dexamethasone) provides any additional benefit to nerve blocks.
Interventions
- DRUG Bupivacaine
- DRUG Dexamethasone
- DRUG Normal saline
- DRUG Lidocaine
- PROCEDURE Greater/lesser occipital nerve blocks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-02-17 |
| Est. Completion | 2025-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05732532
The ClinicalTrials.gov registry entry for NCT05732532 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bupivacaine is the first listed.
NCT05732532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05732532 about?
NCT05732532 is a clinical study titled "Steroids in Occipital Nerve Block for Treatment of Headache". Currently there is limited evidence of benefit for the addition of steroids to occipital nerve blocks for treatment of headache, and not all steroids have been explored. The purpose of this research is to learn more about whether the addition of a specific kind of steroid (dexamethasone) provides an...
What is the current status of trial NCT05732532?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2023-02-17. Estimated completion is 2025-06-01.
What interventions are being tested in trial NCT05732532?
The interventions under investigation include: Bupivacaine (DRUG), Dexamethasone (DRUG), Normal saline (DRUG), Lidocaine (DRUG), Greater/lesser occipital nerve blocks (PROCEDURE).
Who is sponsoring clinical trial NCT05732532?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.